These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37928536)

  • 21. Hepatic arterial infusion oxaliplatin plus raltitrexed and chemoembolization in hepatocellular carcinoma with portal vein invasion: A propensity score-matching cohort study.
    Chen S; Yuan B; Yu W; Wang X; He C; Chen C
    J Surg Oncol; 2022 Dec; 126(7):1205-1214. PubMed ID: 35856502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation and efficacy of TACE combined with lenvatinib plus PD-1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features.
    Zou X; Xu Q; You R; Yin G
    Cancer Med; 2023 May; 12(10):11315-11333. PubMed ID: 36951443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of transcatheter arterial chemoembolization combined with either
    Li Y; Li H; Hu H; Yuan H; Zhao Y
    J Cancer Res Ther; 2020; 16(7):1691-1697. PubMed ID: 33565518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study.
    Yuan Y; He W; Yang Z; Qiu J; Huang Z; Shi Y; Lin Z; Zheng Y; Chen M; Lau WY; Li B; Yuan Y
    Int J Surg; 2023 May; 109(5):1222-1230. PubMed ID: 37026861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
    Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of successful surgical resection after repeated transcatheter arterial chemoembolization for far advanced multiple hepatocellular carcinomas in both lobes associated with Vp₂ portal vein tumor thrombus].
    Maeda S; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2036-8. PubMed ID: 22202276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Chong JU; Choi GH; Han DH; Kim KS; Seong J; Han KH; Choi JS
    Ann Surg Oncol; 2018 Oct; 25(11):3308-3315. PubMed ID: 30083834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.
    Zhang YF; Wei W; Guo ZX; Wang JH; Shi M; Guo RP
    Jpn J Clin Oncol; 2015 Sep; 45(9):837-43. PubMed ID: 26079139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report.
    Sano S; Nakata S; Wada S; Kuroiwa M; Sakai H; Kusama K; Machida T; Nishio A; Ito I; Sodeyama H
    World J Surg Oncol; 2019 Dec; 17(1):229. PubMed ID: 31878937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatocellular Carcinoma with Vp3 Tumor Thrombosis Treated with Multidisciplinary Treatment--Report of Two Cases].
    Mun Y; Yoshidome H; Shinmura K; Nishida T; Sato Y; Nakamura J; Kato K; Oki A; Sasaki S; Miyazaki M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1851-3. PubMed ID: 26805194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus.
    Yang B; Li CL; Guo WH; Qin TQ; Jiao H; Fei ZJ; Zhou X; Duan LJ; Liao ZY
    BMC Cancer; 2018 Jan; 18(1):101. PubMed ID: 29378532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemoembolization (TACE)-hepatic arterial infusion chemotherapy (HAIC) combined with PD-1 inhibitors plus lenvatinib as a preoperative conversion therapy for nonmetastatic advanced hepatocellular carcinoma: a single center experience.
    Zhao W; Liu C; Wu Y; Yao Z; Dou Q; Li W; Zhao X; Xia N
    Transl Cancer Res; 2024 May; 13(5):2315-2331. PubMed ID: 38881913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus.
    Minagawa M; Makuuchi M
    World J Gastroenterol; 2006 Dec; 12(47):7561-7. PubMed ID: 17171782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report.
    Hidaka Y; Tomita M; Desaki R; Hamanoue M; Takao S; Kirishima M; Ohtsuka T
    World J Surg Oncol; 2022 Jul; 20(1):228. PubMed ID: 35831894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature.
    Piardi T; Memeo R; Renard Y; Ammendola M; Bruno O; Habersetzer F; Baumert T; Pessaux P; Sommacale D
    Minerva Chir; 2016 Jun; 71(3):192-200. PubMed ID: 26883849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma.
    Yoo H; Kim JH; Ko GY; Kim KW; Gwon DI; Lee SG; Hwang S
    Ann Surg Oncol; 2011 May; 18(5):1251-7. PubMed ID: 21069467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case.
    Itoh A; Sadamori H; Yabushita K; Monden K; Tatsukawa M; Hioki M; Hyodo T; Omonishi K; Ueki T; Ohno S; Sakaguchi K; Takakura N
    BMC Cancer; 2016 Sep; 16(1):705. PubMed ID: 27586890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
    Wang J; Li X; Wang F; Shi D; Zhang J
    J Cancer Res Ther; 2021 Jul; 17(3):619-624. PubMed ID: 34269290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study.
    Chen S; Yuan B; Yu W; Wang X; He C; Chen C
    J Gastrointest Surg; 2022 Nov; 26(11):2292-2300. PubMed ID: 35920966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.